Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,318 papers from all fields of science
Search
Sign In
Create Free Account
papillary serous adenocarcinoma
Known as:
Papillary Serous Carcinoma
, adenocarcinomas papillary serous
, Papillary Serous Cystadenocarcinoma
Expand
A malignant cystic serous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Adenocarcinoma Cell with Intracytoplasmic Mucin
Bile Ducts, Extrahepatic
Cystic Change
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Immunohistochemical characterization of endocervical papillary serous carcinoma
S. Nofech-Mozes
,
G. Rasty
,
N. Ismiil
,
A. Covens
,
M. Khalifa
International Journal of Gynecologic Cancer
2005
Corpus ID: 43361162
Endocervical adenocarcinomas are rare and aggressive neoplasms. Papillary serous endocervical adenocarcinomas are the rarest form…
Expand
Review
2000
Review
2000
Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Peter S. Craighead
,
Khalid Sait
,
+4 authors
Dianlin Guo
Gynecologic Oncology
2000
Corpus ID: 19982743
OBJECTIVE The aim of this study was to determine the patient characteristics and outcome of patients with aggressive histologic…
Expand
Review
1999
Review
1999
Managing hereditary ovarian cancer risk
A. Berchuck
,
J. Schildkraut
,
J. Marks
,
P. Futreal
Cancer
1999
Corpus ID: 46370342
Ovarian cancer is the fourth leading cause of cancer deaths in American women. About 10% of cases are thought to have a…
Expand
Review
1998
Review
1998
Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
J. Grice
,
Marit Ek
,
+7 authors
Barbara A. Goff
Gynecologic Oncology
1998
Corpus ID: 33232867
OBJECTIVE Earlier studies have demonstrated that the uterine papillary serous carcinoma (UPSC) variant of endometrial carcinoma…
Expand
Highly Cited
1998
Highly Cited
1998
Comparative analysis of histologic homologues of endometrial and ovarian carcinoma.
R. Caduff
,
S. M. Svoboda-Newman
,
R. E. Bartos
,
A. Ferguson
,
T. S. Frank
American Journal of Surgical Pathology
1998
Corpus ID: 26880966
We compared molecular alterations in histologically homologous ovarian and uterine carcinomas, including the prevalence of…
Expand
Highly Cited
1996
Highly Cited
1996
Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
E. Resnik
,
Jerome B. Taxy
Gynecologic Oncology
1996
Corpus ID: 40219366
Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer that frequently imitates serous…
Expand
Highly Cited
1993
Highly Cited
1993
Long‐term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma
P. Mallipeddi
,
N. Teng
,
D. Kapp
Cancer
1993
Corpus ID: 24229080
Background. The optimum management of uterine papillary serous carcinoma (UPSC), a clinically aggressive histologic variant of…
Expand
Highly Cited
1991
Highly Cited
1991
Adjuvant whole‐abdominal radiation therapy in uterine papillary serous carcinoma
A. Frank
,
P. Tseng
,
+9 authors
P. Schwartz
Cancer
1991
Corpus ID: 19597831
Nine patients from 34 to 74 years of age (median, 67 years of age) with uterine papillary serous carcinoma (UPSC) were treated…
Expand
Highly Cited
1986
Highly Cited
1986
Familial ovarian carcinoma. Clinical nuances.
H. T. Lynch
,
C. Bewtra
,
J. Lynch
American Journal of Medicine
1986
Corpus ID: 21545575
1969
1969
Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions.
M. Levi
,
S. Keller
,
I. Mandl
American Journal of Obstetrics and Gynecology
1969
Corpus ID: 27509613
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE